Ligand validation:1PJ3

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 1PJ3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1PJ3_NAD_C_2601	87%	24%	0.096	0.967	1.86	1.3	11	2	1	0	100%	1
1PJ3_NAD_A_601	86%	24%	0.09	0.957	1.83	1.3	11	3	2	0	100%	1
1PJ3_NAD_D_3601	82%	22%	0.1	0.954	1.92	1.31	10	4	1	0	100%	1
1PJ3_NAD_B_1601	68%	22%	0.122	0.933	1.96	1.32	11	3	1	0	100%	1
1PJ3_NAD_B_1602	51%	19%	0.139	0.891	2.08	1.43	11	5	0	0	100%	0.7955
1PJ3_NAD_A_602	49%	17%	0.149	0.894	2.09	1.5	10	6	0	0	100%	0.7955
1PJ3_NAD_C_2602	39%	19%	0.164	0.868	2.01	1.43	9	6	0	0	100%	0.7955
1PJ3_NAD_D_3602	36%	19%	0.169	0.859	2.05	1.44	10	6	0	0	100%	0.7955
7BSJ_NAD_A_601	58%	44%	0.145	0.925	0.9	1.24	3	6	1	0	100%	1
7BSK_NAD_A_602	44%	47%	0.199	0.926	0.84	1.18	3	6	0	0	100%	1
7BSL_NAD_A_602	9%	48%	0.336	0.83	0.81	1.17	1	5	0	0	100%	1
3CMC_NAD_O_407	100%	18%	0.022	0.996	1.63	1.92	4	9	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.